- $3.27bn
- $6.45bn
- $3.18bn
- 81
- 76
- 11
- 57
Annual income statement for RH, fiscal year end - February 1st, USD millions except per share, conversion factor applied.
2021 January 30th | 2022 January 29th | 2023 January 28th | 2024 February 3rd | 2025 February 1st | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 53 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,849 | 3,759 | 3,590 | 3,029 | 3,181 |
| Cost of Revenue | |||||
| Gross Profit | 1,326 | 1,855 | 1,812 | 1,389 | 1,415 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,402 | 2,861 | 3,038 | 2,663 | 2,858 |
| Operating Profit | 447 | 898 | 553 | 366 | 323 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 377 | 830 | 439 | 167 | 88.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 273 | 697 | 531 | 138 | 83.8 |
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 272 | 689 | 529 | 128 | 72.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 272 | 689 | 529 | 128 | 72.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 11.3 | 23 | 18.1 | 6.6 | 5.09 |